Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mirikizumab vs Azathioprine in Newly Diagnosed Moderate-to-severe Ulcerative Colitis
NCT07235904Phase 4Recruiting
- Sponsor
- Universitätsklinikum Schleswig-Holstein
- Start
- Dec 2025
- Primary completion
- Mar 2028
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 4 trial of mirikizumab in ulcerative colitis (UC), sponsored by Universitätsklinikum Schleswig-Holstein. Started Dec 2025; status: recruiting.
02
Drugs
mirikizumab
03
Conditions
ulcerative colitis (UC)
Beyond the preview
Go deeper on NCT07235904.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07235904.